Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor

N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression

(2016) Weronika Krzyzanowska et al.   NEUROTOXICITY RESEARCH

An Integrative Review of Correlates and Predictors of Depression in Patients with Rheumatoid Arthritis

(2015) Monica Iaquinta et al.   ARCHIVES OF PSYCHIATRIC NURSING

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

(2015) Gerwyn Morris et al.   BMC Medicine

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder

(2015) Rita Haapakoski et al.   BRAIN BEHAVIOR AND IMMUNITY

Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders

(2015) Douglas Roberts-Wolfe et al.   CNS & Neurological Disorders-Drug Targets

Major depressive episodes over the course of 7 years and hippocampal subfield volumes at 7 tesla MRI: The PREDICT-MR study

(2015) L.E.M. Wisse et al.   JOURNAL OF AFFECTIVE DISORDERS

Protective effects of N-acetylcysteine against hyperoxaluria induced mitochondrial dysfunction in male wistar rats

(2015) Minu Sharma et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

N-acetylcysteine treatment following spinal cord trauma reduces neural tissue damage and improves locomotor function in mice

(2015) JIAN GUO et al.   Molecular Medicine Reports

N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease

(2015) D J Wright et al.   Translational Psychiatry

An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline

(2014) Rudolf Uher et al.   AMERICAN JOURNAL OF PSYCHIATRY

Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients

(2014) Viktoria Stelzhammer et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The Efficacy of AdjunctiveN-Acetylcysteine in Major Depressive Disorder

(2014) Michael Berk et al.   JOURNAL OF CLINICAL PSYCHIATRY

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

(2014) Olivia Dean et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Prediction of antidepressant treatment response from gray matter volume across diagnostic categories

(2013) Philipp G. Sämann et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

AMPA glutamate receptors mediate the antidepressant-like effects of N-acetylcysteine in the mouse tail suspension test

(2012) Viviane M. Linck et al.   BEHAVIOURAL PHARMACOLOGY

A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity

(2012) Sarah A. Hiles et al.   BRAIN BEHAVIOR AND IMMUNITY

Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance

(2012) Matteo Martino et al.   Current Neuropharmacology

N-Acetylcysteine Reverses Mitochondrial Dysfunctions and Behavioral Abnormalities in 3-Nitropropionic Acid-Induced Huntington’s Disease

(2012) Rajat Sandhir et al.   Neurodegenerative Diseases

Depression and Cardiac Disease

(2011) Christopher M. Celano et al.   Cardiology in Review

The Yin and Yang of Microglia

(2011) Melinda Czeh et al.   DEVELOPMENTAL NEUROSCIENCE

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial

(2011) Michael Berk et al.   JOURNAL OF AFFECTIVE DISORDERS

The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis

(2011) Jonas Hannestad et al.   NEUROPSYCHOPHARMACOLOGY

Serum BDNF levels before treatment predict SSRI response in depression

(2011) Owen M. Wolkowitz et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

N-acetylcysteine for major depressive episodes in bipolar disorder

(2011) Pedro V Magalhães et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Serum brain-derived neurotrophic factor: Determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people

(2011) Boudewijn A.A. Bus et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

EFFECT OF ORAL N-ACETYLCYSTEINE TREATMENT ON PLASMA INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PERITONEAL DIALYSIS PATIENTS: A PLACEBO-CONTROLLED STUDY

(2010) M. M. Nascimento et al.   PERITONEAL DIALYSIS INTERNATIONAL

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression

(2009) Reiji Yoshimura et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications

(2008) Srijan Sen et al.   BIOLOGICAL PSYCHIATRY

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

(2008) André Russowsky Brunoni et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine

(2008) Francesco Matrisciano et al.   JOURNAL OF PSYCHIATRIC RESEARCH